This Report Provides Insight into the Pipeline Status of Atherosclerosis or Coronary Artery Disease Drugs
Posted on: Thursday, 13 September 2007, 06:00 CDT
Research and Markets (http://www.researchandmarkets.com/reports/c68243) has announced the addition of "Cardiovascular and Circulatory System - Atherosclerosis or Coronary Artery Disease Drug Pipeline Report" to their offering.
"Cardiovascular and Circulatory System - Atherosclerosis or Coronary Artery Disease Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of atherosclerosis or coronary artery disease drugs by company and by stage as well as a summary of the latest news and developments in this area.
Scope of the report:
Each Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company's full product pipeline and products by phase of development with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.
Key benefits
Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
Keep track of your competitors and partners by better understanding their product pipeline.
Monitor a company's research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
Maintain a critical competitive advantage.
Atherosclerosis or Coronary Artery Disease Pipeline Overview
--% of Projects (By Phase of Development) --No. of Projects by Phase of Development --Marketed Products Vs. Pipeline Products Company Overview - Pipeline Projects --Company Overview - Pipeline Projects --Legend --Top 20 companies in late stage Atherosclerosis or Coronary Artery Disease Projects --Top 20 companies in early stage Atherosclerosis or Coronary Artery Disease Projects Full Pipeline View --Pre Clinical Pipeline View --Phase I Pipeline View --Phase II Pipeline View --Phase III Pipeline View
For more information visit http://www.researchandmarkets.com/reports/c68243
Life Science Analytics
Source: Business Wire
Related Articles
- Noble Energy Starts Production From Second Phase of Dumbarton Development
- Positron Corporation and Disease Management, LLC Sign Agreement to Co-Develop a Coronary Artery Disease Reversal and Prevention Software Program and Total Disease Management Solution
- Left Main Coronary Artery Disease Genetic
- Baxter Commences First-Of-Its-Kind, Phase II Adult Stem Cell Trial in U.S. In Patients With Severe Coronary Artery Disease
- Effect of Initial Corticosteroid Therapy on Coronary Artery Aneurysm Formation in Kawasaki Disease: A Meta-Analysis of 862 Children
- Noninvasive Diagnosis of Coronary Artery Disease in Patients With Diabetes By Dobutamine Stress Real-Time Myocardial Contrast Perfusion Imaging
- Coronary Artery Disease: The Other Half of the Heaven
- Presence of the Metabolic Syndrome Does Not Impair Coronary Collateral Vessel Formation in Patients With Documented Coronary Artery Disease
- GenVec Launches Phase IIB Trial in Patients With Severe Coronary Artery Disease
 |
 |
User Comments (0)
RSS Feeds